NCPDP held Stakeholder Action Group (SAG) meetings to identify the current and future issues influencing 340B Drug Pricing Program data transparency and program integrity in 2016 and 2017.

    The 340B Task Group, in WG9 Government Programs, used data obtained at those SAG meetings and added current industry guidance to update the 340B Information Exchange Reference Guide in June.

For problems with the site please contact us at